{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:49Z","timestamp":1787026849084,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2018.00338","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T01:29:06Z","timestamp":1542158946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Blood-Based Kinase Assessments in Alzheimer\u2019s Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Jacques","family":"Hugon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mouton-Liger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Cognat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dumurgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00415-008-0770-5","article-title":"Cyclin-dependent kinase 5 is associated with risk for Alzheimer\u2019s disease in a dutch population-based study","volume":"255","author":"Arias-V\u00e1squez","year":"2008","journal-title":"J. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.neurobiolaging.2010.01.004","article-title":"Peripheral expression of key regulatory kinases in Alzheimer\u2019s disease and parkinson\u2019s disease","volume":"32","author":"Armentero","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0014-5793(93)80849-p","article-title":"Abnormal alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5","volume":"336","author":"Baumann","year":"1993","journal-title":"FEBS Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2 and tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1046\/j.1471-4159.2002.01237.x","article-title":"Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2\u03b1 in neuronal degeneration","volume":"83","author":"Chang","year":"","journal-title":"J. Neurochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1097\/00001756-200212200-00011","article-title":"Phosphorylation of eukaryotic initiation factor-2\u03b1 (eIF2\u03b1) is associated with neuronal degeneration in Alzheimer\u2019s disease","volume":"13","author":"Chang","year":"","journal-title":"Neuroreport"},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/039463200802100104","article-title":"expression and phosphorylation of protein kinase c isoforms in A\u03b2(1\u201342) activated T lymphocytes from Alzheimers disease","volume":"21","author":"Ciccocioppo","year":"2008","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.molmed.2004.07.001","article-title":"Cdk5 deregulation in the pathogenesis of Alzheimer\u2019s disease","volume":"10","author":"Cruz","year":"2004","journal-title":"Trends Mol. Med."},{"key":"B9","unstructured":"Association between plasma biomarkers, CDK5 polymorphism and the risk of Alzheimer\u2019s disease397411\n            CzapskiG. A.\n            MaruszakA.\n            Styczy\u0144skaM.\n            \u017bekanowskiC.\n            SafranowK.\n            StrosznajderJ. B.\n          Acta Neurobiol. Exp.722012"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.3390\/v4112598","article-title":"dsRNA-dependent protein kinase PKR and its role in stress, signalling and HCV infection","volume":"4","author":"Dabo","year":"2012","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e53587","DOI":"10.1371\/journal.pone.0053587","article-title":"Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer\u2019s disease","volume":"8","author":"Dumurgier","year":"2013","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.3233\/jad-161221","article-title":"The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state?","volume":"60","author":"Fielder","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1503\/jpn.140062","article-title":"Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline","volume":"40","author":"Gourmaud","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jalz.2018.01.004","article-title":"Plasma amyloid levels within the Alzheimer\u2019s process and correlations with central biomarkers","volume":"14","author":"Hanon","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2004.10.031","article-title":"Glycogen synthase kinase-3 is increased in white cells early in Alzheimer\u2019s disease","volume":"373","author":"Hye","year":"2005","journal-title":"Neurosci. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Mechanisms of tau-induced neurodegeneration","volume":"118","author":"Iqbal","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1038\/tp.2014.61","article-title":"Plasma DYRK1A as a novel risk factor for Alzheimer\u2019s disease","volume":"4","author":"Janel","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma \u03b2-amyloid in Alzheimer\u2019s disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neurobiolaging.2005.02.009","article-title":"Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer\u2019s disease but not for Parkinson\u2019s disease","volume":"27","author":"Janoshazi","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.1038\/tp.2015.78","article-title":"Plasma protein biomarkers of Alzheimer\u2019s disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes","volume":"5","author":"Kiddle","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1471-4159.2005.03187.x","article-title":"mTOR\/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer\u2019s disease","volume":"94","author":"Lafay-Chebassier","year":"2005","journal-title":"J. Neurochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neulet.2007.01.034","article-title":"Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer\u2019s disease","volume":"415","author":"Leosco","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0304-3940(96)13310-3","article-title":"NMDA induces apoptosis and necrosis in neuronal cultures. increased APP immunoreactivity is linked to apoptotic cells","volume":"221","author":"Lesort","year":"1997","journal-title":"Neurosci. Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/jad-143006","article-title":"Biomarkers in sporadic and familial Alzheimer\u2019s disease","volume":"47","author":"Lista","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/jad-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1093\/hmg\/ddv092","article-title":"Genetics of CD33 in Alzheimer\u2019s disease and acute myeloid leukemia","volume":"24","author":"Malik","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.exger.2009.02.007","article-title":"Glycogen-synthase kinase-3\u03b2 is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairment","volume":"44","author":"Marksteiner","year":"2009","journal-title":"Exp. Gerontol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1523\/jneurosci.10-07-02113.1990","article-title":"Differential involvement of protein kinase C isozymes in Alzheimer\u2019s disease","volume":"10","author":"Masliah","year":"1990","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.biopsych.2011.11.031","article-title":"Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer\u2019s disease","volume":"71","author":"Mouton-Liger","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","article-title":"Targeting p38 MAPK pathway for the treatment of Alzheimer\u2019s disease","volume":"58","author":"Munoz","year":"2010","journal-title":"Neuropharmacology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/bf03033333","article-title":"Overexpression of GRK2 in alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions","volume":"10","author":"Obrenovich","year":"2006","journal-title":"Neurotox. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1074\/mcp.m800588-mcp200","article-title":"Large-scale proteomics analysis of the human kinome","volume":"8","author":"Oppermann","year":"2009","journal-title":"Mol. Cell Proteomics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.neulet.2006.07.053","article-title":"Peripheral p70S6k levels and emotional memory in patients with Alzheimer\u2019s disease","volume":"410","author":"Paccalin","year":"","journal-title":"Neurosci. Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000095562","article-title":"Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer\u2019s disease","volume":"22","author":"Paccalin","year":"","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1001\/archinte.165.20.2428","article-title":"The relation between p70S6k expression in lymphocytes and the decline of cognitive test scores in patients with alzheimer disease","volume":"165","author":"Paccalin","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0167273","DOI":"10.1371\/journal.pone.0167273","article-title":"Enhanced activities of blood thiamine diphosphatase and monophosphatase in Alzheimer\u2019s disease","volume":"12","author":"Pan","year":"2017","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","article-title":"mTOR-dependent signalling in Alzheimer\u2019s disease","volume":"12","author":"Pei","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","article-title":"Distribution, levels and activity of glycogen synthase kinase-3 in the alzheimer disease brain","volume":"56","author":"Pei","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1046\/j.1471-4159.2001.00102.x","article-title":"Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer\u2019s disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3)","volume":"76","author":"Standen","year":"2009","journal-title":"J. Neurochem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.2174\/1567205013666160615091821","article-title":"Drug development of small-molecule inhibitors of ad-relevant kinases as novel perspective multitargeted approach","volume":"13","author":"Tell","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jocn.2013.08.017","article-title":"Peripheral expression of MAPK pathways in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"21","author":"Wang","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/prca.200700102","article-title":"Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets","volume":"1","author":"Yu","year":"2007","journal-title":"Proteomics Clin. Appl."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00338\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T01:29:19Z","timestamp":1542158959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2018.00338\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":47,"alternative-id":["10.3389\/fnagi.2018.00338"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2018.00338","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"article-number":"338"}}